NO178343C - Fremgansmåte for fremstilling av terapeutisk aktiv 1-[4,5-dihydroksy-N2-(10,12-dimethyl-1-oxotetradecyl)-ornithinÅ-5-(3-hydroxyglutamin)-6-[3-hydroxyprolinÅechinocandin B - Google Patents

Fremgansmåte for fremstilling av terapeutisk aktiv 1-[4,5-dihydroksy-N2-(10,12-dimethyl-1-oxotetradecyl)-ornithinÅ-5-(3-hydroxyglutamin)-6-[3-hydroxyprolinÅechinocandin B

Info

Publication number
NO178343C
NO178343C NO902921A NO902921A NO178343C NO 178343 C NO178343 C NO 178343C NO 902921 A NO902921 A NO 902921A NO 902921 A NO902921 A NO 902921A NO 178343 C NO178343 C NO 178343C
Authority
NO
Norway
Prior art keywords
dihydroxy
preparation
therapeutically active
cultivation
isolation
Prior art date
Application number
NO902921A
Other languages
English (en)
Norwegian (no)
Other versions
NO178343B (no
NO902921D0 (no
NO902921L (no
Inventor
Robert E Schwartz
Raymond F White
Jerrold M Liesch
Otto D Hensens
Henry Joshua
Dennis M Schmatz
Robert A Giacobbe
Jan S Tkacz
Prakash S Masurekar
Louis Kaplan
Margaret S Sosa
Jimmy M Fountoulakis
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/492,026 external-priority patent/US5021341A/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NO902921D0 publication Critical patent/NO902921D0/no
Publication of NO902921L publication Critical patent/NO902921L/no
Publication of NO178343B publication Critical patent/NO178343B/no
Publication of NO178343C publication Critical patent/NO178343C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
NO902921A 1989-06-30 1990-06-29 Fremgansmåte for fremstilling av terapeutisk aktiv 1-[4,5-dihydroksy-N2-(10,12-dimethyl-1-oxotetradecyl)-ornithinÅ-5-(3-hydroxyglutamin)-6-[3-hydroxyprolinÅechinocandin B NO178343C (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US37441689A 1989-06-30 1989-06-30
US49202590A 1990-03-12 1990-03-12
US49202490A 1990-03-12 1990-03-12
US07/492,026 US5021341A (en) 1990-03-12 1990-03-12 Antibiotic agent produced by the cultivation of Zalerion microorganism in the presence of mannitol

Publications (4)

Publication Number Publication Date
NO902921D0 NO902921D0 (no) 1990-06-29
NO902921L NO902921L (no) 1991-01-02
NO178343B NO178343B (no) 1995-11-27
NO178343C true NO178343C (no) 1996-03-06

Family

ID=27503114

Family Applications (1)

Application Number Title Priority Date Filing Date
NO902921A NO178343C (no) 1989-06-30 1990-06-29 Fremgansmåte for fremstilling av terapeutisk aktiv 1-[4,5-dihydroksy-N2-(10,12-dimethyl-1-oxotetradecyl)-ornithinÅ-5-(3-hydroxyglutamin)-6-[3-hydroxyprolinÅechinocandin B

Country Status (16)

Country Link
EP (1) EP0405997B1 (ja)
JP (1) JPH0764873B2 (ja)
KR (1) KR0145693B1 (ja)
AT (1) ATE109160T1 (ja)
AU (1) AU639698B2 (ja)
CA (1) CA2020062C (ja)
CY (1) CY1962A (ja)
DE (1) DE69011006T2 (ja)
DK (1) DK0405997T3 (ja)
ES (1) ES2057413T3 (ja)
FI (1) FI93647C (ja)
HK (1) HK209496A (ja)
IL (1) IL94862A (ja)
NO (1) NO178343C (ja)
NZ (1) NZ234225A (ja)
PT (1) PT94555B (ja)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2037957A1 (en) * 1990-03-12 1991-09-13 Merck & Co., Inc. N-acylated cyclohexapeptide compounds
US5310873A (en) * 1990-03-12 1994-05-10 Merck & Co., Inc. Cyclohexapeptide compound
US5330973A (en) 1990-03-19 1994-07-19 Merck & Co., Inc. Lipopeptide derivatives
JPH06502536A (ja) * 1990-10-09 1994-03-24 メルク　エンド　カンパニー　インコーポレーテッド 有機化合物の新規生物学的リン酸化方法
US5219985A (en) * 1990-10-31 1993-06-15 Merck & Co., Inc. Antifungal agent
US5229363A (en) * 1991-02-19 1993-07-20 Merck & Co., Inc. Cyclic hexapeptide compounds
US5369093A (en) * 1991-03-15 1994-11-29 Merck & Co., Inc. Lipopeptide derivatives
US5336756A (en) * 1991-05-01 1994-08-09 Merck & Co., Inc. Process for crystalline cyclic lipopeptides
US6030944A (en) * 1991-10-01 2000-02-29 Merck & Co., Inc. Cyclohexapeptidyl bisamine compounds
US5348940A (en) * 1991-10-01 1994-09-20 Merck & Co., Inc. Cyclohexapeptidyl hydroxypropionitrile compounds
EP0539088B1 (en) * 1991-10-17 1996-07-17 Merck & Co. Inc. Echinocandin b derivative
US5914313A (en) * 1991-10-17 1999-06-22 Merck & Co., Inc. 1- 4-hydroxy-5-aminoethyloxy-N2 -(10,12-dimethyl-1-oxotetradecyl)ornithine!-5-(3-hydroxyglutamine)-6-(3-hydroxyproline)echinocandin B, other aminoalkyl derivatives and salts thereof
US5378804A (en) * 1993-03-16 1995-01-03 Merck & Co., Inc. Aza cyclohexapeptide compounds
CA2161149A1 (en) * 1993-05-04 1994-11-10 James M. Balkovec Cyclohexapeptidyl aminoalkyl ethers
EP1646370A1 (en) * 2003-07-11 2006-04-19 Glaxo Group Limited Pharmaceutical formulations
CN102618604B (zh) * 2011-01-31 2014-09-03 上海天伟生物制药有限公司 一种环脂肽化合物的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1183127A (en) * 1979-12-13 1985-02-26 Manuel Debono Process for the preparation of derivatives of cyclic peptide nuclei
CA1182812A (en) * 1979-12-13 1985-02-19 Bernard J. Abbott Process for the preparation of derivatives of cyclic peptide nuclei
JPS57501266A (ja) * 1980-08-15 1982-07-22
DE3886001T2 (de) * 1987-10-07 1994-05-26 Merck & Co Inc Fungizides Fermentationsprodukt.

Also Published As

Publication number Publication date
DE69011006T2 (de) 1995-01-26
EP0405997A1 (en) 1991-01-02
NO178343B (no) 1995-11-27
JPH03163096A (ja) 1991-07-15
PT94555B (pt) 1997-02-28
CA2020062C (en) 1997-01-14
IL94862A0 (en) 1991-04-15
NO902921D0 (no) 1990-06-29
HK209496A (en) 1996-11-29
ES2057413T3 (es) 1994-10-16
JPH0764873B2 (ja) 1995-07-12
DK0405997T3 (da) 1994-10-31
AU639698B2 (en) 1993-08-05
DE69011006D1 (de) 1994-09-01
FI903280A0 (fi) 1990-06-28
FI93647C (fi) 1995-05-10
EP0405997B1 (en) 1994-07-27
KR910001068A (ko) 1991-01-30
PT94555A (pt) 1991-05-22
FI93647B (fi) 1995-01-31
CA2020062A1 (en) 1990-12-31
ATE109160T1 (de) 1994-08-15
IL94862A (en) 1994-10-07
CY1962A (en) 1997-07-04
NZ234225A (en) 1993-09-27
KR0145693B1 (ko) 1998-08-01
AU5797390A (en) 1991-01-03
NO902921L (no) 1991-01-02

Similar Documents

Publication Publication Date Title
NO178343C (no) Fremgansmåte for fremstilling av terapeutisk aktiv 1-[4,5-dihydroksy-N2-(10,12-dimethyl-1-oxotetradecyl)-ornithinÅ-5-(3-hydroxyglutamin)-6-[3-hydroxyprolinÅechinocandin B
MX9702531A (es) Compuesto nuevo.
NO903286L (no) Antibakterielle midler.
EP0311194A3 (en) Process for antifungal fermentation product and culture
ATE78490T1 (de) Glykopeptid-antibiotika.
ES2067520T3 (es) Antibioticos y procedimiento para su produccion.
DE69104022D1 (de) Antibiotisches zyklisches Hexapeptid.
ES2094757T3 (es) Un factor megacariocitopoyetico.
DK0675900T3 (da) Antibiotika GE 37468 A, B og C
ES2035829T3 (es) Procedimiento para obtener un preparado farmaceutico para el tratamiento de infecciones bactertianas.
ATE4637T1 (de) Pentadecapeptid, verfahren zu seiner herstellung und immunisierendes mittel.
EA200101171A1 (ru) Способ лечения инфекций, вызванных streptococcus pneumoniae
DE69429447D1 (de) Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 7 infektionen
Sous et al. Bactericidal activity of phenoxymethylpenicillin in an in-vitro model simulating tissue kinetics
EP0189587A3 (en) Method of sterilizing recombinant microorganism
ES2131105T3 (es) Composiciones farmaceuticas de pentapeptidos y procedimientos de uso de las mismas.
DE69429538D1 (de) Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 6 infektionen
SE8400450L (sv) Nytt cykliskt depsipeptidantibiotikum, forfarande for framstellning derav samt farmaceutiska kompositioner innehallande det nya antibiotikumet
RU94026368A (ru) Вещество, обладающее антиадгезионной активностью к грамположительной микрофлоре
NO923298L (no) Blandinger og fremgangsmaater for behandling av infeksjoner foraarsaket av organismer som er foelsomme for beta-laktam-antibiotika
TH9958A (th) การเตรียมยาปฏิชีวนะไกลโคเพบไทด์
AU6725387A (en) Drugs for the treatment and cure of all infectious diseases caused by pathogenic virulent micro-organisms
BG96634A (en) Method for the preparation of antibiotic complex

Legal Events

Date Code Title Description
MK1K Patent expired